Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02574351 · ClinicalTrials.gov registry record
Study of T-Regulatory Cells in Asthma
A clinical trial, sponsored by Northwell Health.
- Completed
- Registry status
- 66
- Enrollment target
NCT02574351: Completed study, sponsored by Northwell Health.
NCT02574351 is a clinical trial that has completed, run by Northwell Health. The registered enrollment target is 66 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02574351 has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- 66 participants
- Enrollment target
Study Summary
To study whether the immune response as directed by regulatory T cells is different between obese asthmatics, normal weight asthmatics and healthy controls.
Interventions
- BIOLOGICAL blood draw, breathing test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2011-05 |
| Est. Completion | 2015-12 |
What the finished NCT02574351 record still lists
NCT02574351 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 66 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which blood draw, breathing test is the first listed.
NCT02574351 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02574351 about?
NCT02574351 is a clinical study titled "Study of T-Regulatory Cells in Asthma". To study whether the immune response as directed by regulatory T cells is different between obese asthmatics, normal weight asthmatics and healthy controls.
What is the current status of trial NCT02574351?
This trial is currently completed. The enrollment target is 66 participants. The study started on 2011-05. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02574351?
The interventions under investigation include: blood draw, breathing test (BIOLOGICAL).
Who is sponsoring clinical trial NCT02574351?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia